32 results
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
30 Jan 24
Third party tender offer statement (amended)
8:23am
financial statements, minus (ii) the sum of Theseus’ consolidated short-term and long-term contractual obligations and liabilities (including indebtedness … that determination. Any capital gain or loss recognized will be long-term capital gain or loss if the Holder’s holding period for such Shares exceeds one year
SC 14D9
THRX
Theseus Pharmaceuticals Inc
10 Jan 24
Tender offer solicitation
9:47am
and short- and long-term operating plans, assets, liabilities and financial condition of the Company if it continued to operate independently
SC TO-T
EX-99
Concentra Merger Sub II, Inc.
10 Jan 24
Third party tender offer statement
8:51am
thereof in Theseus’ consolidated financial statements, minus (ii) the sum of Theseus’ consolidated short-term and long-term contractual obligations … statements, minus (ii) the sum of Theseus’ consolidated short-term and long-term contractual obligations and liabilities (including indebtedness) accrued
8-K
EX-2.1
THRX
Theseus Pharmaceuticals Inc
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
consolidated short-term and long-term contractual obligations and liabilities (including Indebtedness) accrued or incurred by or on behalf of the Company … obligations under any short-term or long-term contracts, including any installment sale contracts, (iv) all guarantees and arrangements having
8-K
EX-99.1
lh8tu9xq5pl9
10 Aug 23
Theseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial Results
7:05am
8-K
EX-99.2
aphrw2w0879x6nxh4zdp
25 May 23
Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST
5:04pm
8-K
EX-99.1
o6fqrz71
11 May 23
Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2023 Financial Results
7:09am
PRE 14A
r6bstow
14 Apr 23
Preliminary proxy
9:00am
S-3
EX-1.2
6i2ztdtoe4s8bfxi27
3 Nov 22
Shelf registration
9:06am
8-K
EX-99.1
48rk379je0
3 Nov 22
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Third
7:00am
8-K
EX-99.1
jwi3j8pix95m
11 Aug 22
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Second
7:15am
8-K
EX-99.1
7rjfgaqo6 zpv47rrl
12 May 22
Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2022 Financial Results
7:15am
DEF 14A
kenrjp68hpzey1mlk
25 Apr 22
Definitive proxy
4:30pm